Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Katerina Chatzidionysiou, Elisabeth Lie, Evgeny Nasonov, Galina Lukina, Merete Lund Hetland, Ulrik Tarp, Ioan Ancuta, Karel Pavelka, Dan C Nordström, Cem Gabay, Helene Canhão, Matija Tomsic, Piet L. C. M. van Riel, Juan Gomez-Reino, Tore K. Kvien, Ronald F van Vollenhoven

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)144
JournalArthritis Research & Therapy
Volume18
Issue number1
DOIs
Publication statusPublished - 20 Jun 2016

Cite this

Chatzidionysiou, K., Lie, E., Nasonov, E., Lukina, G., Hetland, M. L., Tarp, U., Ancuta, I., Pavelka, K., Nordström, D. C., Gabay, C., Canhão, H., Tomsic, M., van Riel, P. L. C. M., Gomez-Reino, J., Kvien, T. K., & van Vollenhoven, R. F. (2016). Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration. Arthritis Research & Therapy, 18(1), 144. https://doi.org/10.1186/s13075-016-1048-4